Centre approves Sanofi’s FDI proposal amounting Rs 180 crore

08 May 2013 Evaluate

The Centre has approved 17 proposals for foreign direct investment (FDI) amounting to Rs 262.56 crore, which include pharmaceutical company Sanofi’s application to invest Rs 180 crore to acquire another pharma company. The company plans to invest the acquisition via internal accruals.

Meanwhile, other approvals include Rs 70 crore brought in by Augere Wireless Broadband to capitalise the balance amount of the spectrum fee earlier paid to the Department of Telecommunications, induction of Rs 7.65 crore by Na Pali Europe SARL’s in an Indian company to carry out single brand retail trading and issue and allotment of shares issued towards pre-incorporation expenses to carry out the business of manufacture of Auxillary equipment used in Plastic/Polymers processing industry worth Rs 2.54 crore by Zap Piling India, Chennai, on incorporation of the company.

In India, Sanofi operates through five entities - Sanofi India (previously known as Aventis Pharma), Sanofi-Synthelabo (India), Sanofi Pasteur India, Shantha Biotechnics and Genzyme India.

Sanofi India Share Price

4272.35 -62.05 (-1.43%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×